Viewing data from:

ISOSULFAN BLUE

ANDA

ISOSULFAN BLUE | A210714 | SABA ILAY SANAYI VE TICARET AS

1 strength0 unique patents0 unique exclusivities

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Beloteca, Inc. v. Apicore US LLC et al 1:2019cv00360 3 patentsANDA 210714, 90874isosulfan blue	N.D. Ill.	2019-01-17	Terminated 2019-04-08	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain8 active DMFs1 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

MYLAN PHARMACEUTICALS INC A VIATRIS COISOSULFAN BLUE

DMF 218832008

APITORIA PHARMA PRIVATE LTDISOSULFAN BLUE

DMF 277952013

BIOPHORE INDIA PHARMACEUTICALS PVT LTDISOSULFAN BLUE

DMF 298292015

DISHMAN CARBOGEN AMCIS LTDISOSULFAN BLUE

DMF 312262016

EMCURE PHARMACEUTICALS LTDISOSULFAN BLUE

DMF 331992018

MSN LABORATORIES PRIVATE LTDISOSULFAN BLUE

DMF 347172020

AGNO PHARMAISOSULFAN BLUE

DMF 349752020

SUVEN PHARMACEUTICALS LTDISOSULFAN BLUE

DMF 372582022

SAFC PHARMAInactiveISOSULFAN BLUE

DMF 208912007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 50MG/5ML (10MG/ML)

0 patents0 exclusivities▴

SOLUTION;SUBCUTANEOUS | Approved: Jan 16, 2019

No patent or exclusivity listings for this strength.